Skip to main content

Table 3 Incidence of ALRI hospitalisation and clinic presentation episodes among infants (age < 12 months) of pregnancy vaccinees versus controls

From: Impact of the 23-valent pneumococcal polysaccharide vaccination in pregnancy against infant acute lower respiratory infections in the Northern Territory of Australia

 

23vPPV in Pregnancy

  

Yes (n = 75)

No (n = 150)

  

Children,

n (%)

Episodes,

n

Child-years

IR

Children,

n (%)

Episodes,

n

Child-years

IR

HR (95%CI)

aHR (95%CI)

ALRI hospital

6 (8)

9

73.1

12.3

19 (13)

23

145.9

15.8

0.77 (0.29,2.03)

0.92 (0.34,2.47)

ALRI clinic#

18 (78)

45

20.9

215

34 (72)

81

43.0

188

1.13 (0.67,1.93)

1.24 (0.76,2.03)

  1. ALRI acute lower respiratory infection, IR incidence rate per 100 child-years. HR hazard ratio, aHR adjusted hazard ratio, 95%CI 95% confidence interval. After stepwise elimination the covariates: remote dwelling, maternal smoking in pregnancy and breast feeding duration (time dependent) were included in the final ALRI hospital model; missing breast feeding duration data (n = 11) were imputed. After stepwise elimination the covariates: PCV doses (time dependent), breast feeding duration (time dependent) and maternal smoking during infancy were included in the final ALRI clinic presentation model. #ALRI clinic presentation data were only available for the 70 infants from remote communities (23vPPV n = 23; no 23vPPV n = 47); missing maternal smoking during infancy data (n = 7) were imputed